...
首页> 外文期刊>Kosuyolu Kalp Dergisi >Is Rheumatic Mitral Valve Disease Still Maintaining its Prevalence in Our Country? Early and Long-term Outcomes After Mitral Valve Replacement with Rheumatic Origin
【24h】

Is Rheumatic Mitral Valve Disease Still Maintaining its Prevalence in Our Country? Early and Long-term Outcomes After Mitral Valve Replacement with Rheumatic Origin

机译:风湿性二尖瓣疾病在我国仍保持流行吗?风湿性起源的二尖瓣置换术后的早期和长期结果

获取原文
           

摘要

Introduction: The purpose of this study was to present early and long-term results of mitral valve replace- ment in the treatment of rheumatic mitral valve disease, encountered frequently as an etiology in our clinic. Patients and Methods: All patients undergoing mitral valve replacement in our clinic between July 2008 and December 2017 were retrospectively reviewed. Patients with rheumatic mitral stenosis and/or regurgitation were included in the study. Primary outcome of interest was early mortality rates, long-term survival rates, and independent predictors of long-term survival. Results: In total, 88 patients were included in the study. Early mortality was observed in 4 (4.5%) patients. Concomitant arrhythmia surgery was performed in 19 (21.6%) patients with preoperative atrial fibrillation, and 11 of the 19 (12.5%) patients showed sinus rhythm after the operation. Overall 5-year survival rate was 77.9%. When compared to the valve pathologies, 5-year survival rates was 72.6% in patient group with iso- lated mitral stenosis, 81.8% in patient group with isolated mitral regurgitation, and 86.7%, in patient group with combined mitral stenosis and regurgitation. There was no statistically significant difference among the groups (p= 0.63). The existence of preoperative chronic renal failure (HR, 33.4; 95% CI, 4.1-272.3; p= 0.001) and cardiopulmonary bypass time (HR, 1.05; 95% CI, 1.02-1.08; p 0.001) were independent predictors of long-term survival. Conclusion: Rheumatic mitral valve disease remains a problem in our country due to rural and border migration. Valve replacement is an optimal choice and produces satisfactory results in terms of prevention of recurrence and provision of effective valve orifice area. In addition, it is necessary to take precautions in the presence of preopera- tive chronic renal failure and to avoid prolonged cardiopulmonary bypass periods during the operation to ensure long term survival.
机译:简介:本研究的目的是介绍风湿性二尖瓣疾病的二尖瓣置换术的早期和长期结果,这在我们的临床中是一种病因。患者与方法:回顾性分析2008年7月至2017年12月在我们诊所接受二尖瓣置换术的所有患者。风湿性二尖瓣狭窄和/或反流的患者纳入研究。感兴趣的主要结果是早期死亡率,长期生存率以及长期生存的独立预测因子。结果:总共88例患者被纳入研究。在4名(4.5%)患者中观察到早期死亡率。 19例(21.6%)术前房颤患者同时进行心律失常手术,而19例(12.5%)的患者中有11例术后窦性心律。总体5年生存率为77.9%。与瓣膜病变相比,孤立性二尖瓣狭窄患者组的5年生存率是72.6%,孤立性二尖瓣关闭不全的患者组的81.8%,二尖瓣狭窄合并反流的患者组的86.7%。各组之间无统计学差异(p = 0.63)。术前慢性肾功能衰竭(HR,33.4; 95%CI,4.1-272.3; p = 0.001)和体外循环时间(HR,1.05; 95%CI,1.02-1.08; p <0.001)的存在是长期预测的独立预测因素长期生存。结论:由于农村和边境移民,风湿性二尖瓣疾病在我国仍然是一个问题。阀的更换是最佳选择,并且在防止复发和提供有效的阀孔面积方面产生令人满意的结果。此外,有必要在术前慢性肾功能衰竭的情况下采取预防措施,并避免手术期间延长体外循环时间,以确保长期生存。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号